Efficacy of New Antituberculosis Drugs in Patients with Extensive Drug Resistance

Authors

  • Gyulbala GADJIEV Institutul de Boli Pulmonare al Ministerului Sănătății din Republica Azerbaidjan
  • Emilia ABDULLAEVA Institute of Pulmonary Diseases of the Ministry of Health of the Republic of Azerbaijan
  • Nazilya MURGUZOVA Institutul de Boli Pulmonare al Ministerului Sănătății din Republica Azerbaidjan

DOI:

https://doi.org/10.52692/1857-0011.2024.2-79.08

Keywords:

Antituberculosis drugs, adverse reactions, extensively drug-resistant tuberculosis, treatment effectiveness, chemotherapy

Abstract

The study aimed to evaluate the effectiveness of new antituberculosis drugs in patients with extensively drug-resistant tuberculosis. A retrospective analysis of data from 178 patients revealed key findings.One of the main outcomes was the cessation of bacterial excretion in 40.5% of patients after just six months of treatment. However, the therapy was associated with adverse reactions in 46.6% of cases. The most common side effects were gastrointestinal disturbances (21.3%) and hepatological issues (13.5%).Drugs like bedaquiline, linezolid, clofazimine, and fluoroquinolones demonstrated high efficacy, ensuring good patient adherence to treatment. The study confirmed that new chemotherapy regimens significantly improve treatment outcomes and accelerate patient recovery.

Author Biographies

Gyulbala GADJIEV, Institutul de Boli Pulmonare al Ministerului Sănătății din Republica Azerbaidjan

Doctor of Medical Sciences

Emilia ABDULLAEVA, Institute of Pulmonary Diseases of the Ministry of Health of the Republic of Azerbaijan

Candidate of Medical Sciences

Nazilya MURGUZOVA, Institutul de Boli Pulmonare al Ministerului Sănătății din Republica Azerbaidjan

Candidate of Medical Sciences

References

Васильев И.А. Сомойлова А.Г., Ридакова А.В. и др. Экономическое обоснование применения новых схем химиотерапии для лечения больных туберкулезом с широкой лекарственной устойчивостью. Туберкулез легких. – 2018- Т.96 №6-с.7-16

Кильдюшева Е.И., Егоров Е.А., Скорняков С.Н. и др. Клиническая результативность новых лекарственных препаратов в схемах лечения туберкулеза с множественной и широкой лекарственной устойчивостью. РМЖ – 2017- т25; № 18- с.1288-1295

Global tuberculosis report – 2019 Geneva: Wirld Health Organization 2019. Licerce: CC BY –NC- SA 3.0 IGO

Axundov İ.M., Hacıyev G S., Rəhmanov N.O., Əkbərova Z.S., Geniş gedişli dərmanlara davamlı vərəm xəstələrinin müalicəsonn xüsusiyyətləri. Tezis.

Борисов С.Е., Филипов А.В., Иванушкина Т.Н., Литвинова Н.В., Гарман Ю.Ю. Эффективность и безопасность основанных на использовании бедаквилина режимов химиотерапии у больных туберкулезом органов дыхания: непосредственные и окончательные результаты. Туберкулез и болезни легких. 2019 Т 97, №5- 28-42

World Health Organization et al. Global tuberculosis report 2020. Vol 4- 250p.

Старшикова А.А., Назаренко М.М., Беляева Е.Н., Кудлай Д.А., Павлова М.В., Явлонский П.К. Туберкулез и болезни легких. 2022, Т. 100; №5; с. 56-63.

Published

2025-04-18

Issue

Section

Research Article

Categories